A detailed history of Ensign Peak Advisors, Inc transactions in Embecta Corp. stock. As of the latest transaction made, Ensign Peak Advisors, Inc holds 20,115 shares of EMBC stock, worth $418,995. This represents 0.0% of its overall portfolio holdings.

Number of Shares
20,115
Previous 20,115 -0.0%
Holding current value
$418,995
Previous $251,000 12.75%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

SELL
$12.35 - $19.33 $12,535 - $19,619
-1,015 Reduced 4.8%
20,115 $266,000
Q4 2023

Feb 14, 2024

BUY
$12.87 - $19.09 $45,045 - $66,815
3,500 Added 19.85%
21,130 $399,000
Q1 2023

May 15, 2023

BUY
$23.07 - $32.77 $49,600 - $70,455
2,150 Added 13.89%
17,630 $495,000
Q4 2022

Feb 13, 2023

BUY
$25.29 - $35.48 $34,141 - $47,897
1,350 Added 9.55%
15,480 $391,000
Q2 2022

Aug 12, 2022

BUY
$24.78 - $33.36 $350,141 - $471,376
14,130 New
14,130 $358,000

Others Institutions Holding EMBC

About Embecta Corp.


  • Ticker EMBC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 57,836,500
  • Market Cap $1.2B
  • Description
  • Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to whole...
More about EMBC
Track This Portfolio

Track Ensign Peak Advisors, Inc Portfolio

Follow Ensign Peak Advisors, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ensign Peak Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ensign Peak Advisors, Inc with notifications on news.